Investing Profile

Elena Viboch

InvestorVC
Partner at General Catalyst
generalcatalyst.comSan Francisco Bay Area
Photo of Elena Viboch, Partner at General Catalyst
Your Intro Paths to Elena Viboch

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Elena Viboch's investing connections

Picture
Picture

2 Investors

Connected to Saar Gur (CRV), Lisa Marrone (August Capital).

Find Elena Viboch on

cb
Current Investing Position
General Catalyst Partner
Investment Range
$500K - $2.0M
Sweet Spot
$500K
Investments On Record
11
Current Fund Size
$1.1B

Elena Viboch is on these Sector & Stage Rankings

Elena Viboch's Investments On Record (10)

CompanyStageDateRound SizeTotal Raised
Maxion Therapeutics
Series AMar 2025$75M
$91M
Co-investors: Lucy Edwardes-Jones (Business Growth Fund)
Medeloop
Series ANov 2024$16M
SeedSep 2023$8M
$24M
Co-investors: Sara Thomas Deshpande (Maven Ventures), Magaly Charbonneau (iNovia Capital)
CTRL Therapeutics
SeedApr 2023$10M
$10M
Faro Health
Series AFeb 2023$20M
$35M
Co-investors: Andy Harrison (Section 32)
Paradigm
Series AJan 2023$200M
$250M
Co-investors: Ramnik Arora (FTX Ventures), Hemant Taneja (General Catalyst), Niko Bonatsos (General Catalyst), Bilal Zuberi (Lux Capital), Brett Cook (F-Prime Capital Partners), Stephen Knight (F-Prime Capital Partners), Alaa Halawa (Mubadala), Jay Markowitz (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners), Jared Friedman (Y Combinator), Scott Belsky, Arash Ferdowsi, Eoghan McCabe, Karim Atiyeh, Balaji Srinivasan
ArriVent Biopharma
Series BDec 2022$160M
$160M
Co-investors: Carl Gordon (OrbiMed), James Healy (Sofinnova Investments)
Vial
Series BNov 2022$67M
$100M
Co-investors: David Tisch (BoxGroup), Josh Buckley (Buckley Ventures), Greg Rosen (BoxGroup), Hemant Taneja (General Catalyst), Jeffrey Silverstein (Andreessen Horowitz), Nimi Katragadda (BoxGroup), Adam Rothenberg (BoxGroup), Blake Byers (Byers Capital), TJ Nahigian (Base10 (Base10 Partners) ), Nikhil Krishnan, Gordon Wintrob, Zak Kukoff
Odyssey Therapeutics
Series BOct 2022$170M
$700M
Co-investors: Carl Gordon (OrbiMed), Nan Li (Dimension Capital), Jill carroll (SR One), Lorence Kim (Third Rock Ventures)